Tests treatment plans for liver cancer in children and teens
Tests tailored treatments for liver cancer in children and adolescents, by disease stage.
Key facts
- Who runs it
- Medical University Of Gdansk
- Where
- Białystok, Bydgoszcz, Gdansk, Katowice, Krakow, Łódź, Lublin, Poznań, Rzeszów, Szczecin, Warsaw, Wrocław, and Zabrze, PolandSee the 14 sites
- Registry title
- A clinical trial in children and adolescents with primary malignant liver cancer - Hepatoblastoma and Hepatocarcinoma
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 60 people, planned
- Started
- 28 Aug 2025
- Expected to end
- 29 Sept 2027
- Type of study
- Interventional
- Record updated
- 5 June 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and young people with a malignant liver tumor (hepatoblastoma or hepatocarcinoma) who have not yet had chemotherapy.
- Age
- Under 30 years.
- Sex
- All sexes can join.
- Disease stage
- Clinical signs of hepatoblastoma or hepatocarcinoma, with a liver tumor.
- Earlier treatment
- Cannot have had chemotherapy before or be receiving it now.
Main reasons for not taking part
- Previous or current chemotherapy
- Disease that has come back
- Condition after an organ transplant
- Uncontrolled infection throughout the body
- Pregnancy or breastfeeding
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Clinically signs of Hepatoblastoma or Hepatocarcinoma (malignant tumors of the liver) + liver tumor; Age under 30; Signing informed consent to participate in the Study
Who cannot take part
- Previously or currently receiving chemotherapy treatment; Recurrence of the disease; Condition after organ transplantation; Uncontrolled generalized infection; Inability to conduct the Study in accordance with the Protocol; Other Associated Cancer; Pregnancy or breastfeeding
Where in Poland
- Uniwersytecki Dziecięcy Szpital Kliniczny im. Ludwika Zamenhofa w BiałymstokuBiałystok, PolandTaking people
- Szpital Uniwersytecki nr 1 im. dr Antoniego Jurasza w BydgoszczyBydgoszcz, PolandTaking people
- Medical University Of GdanskGdansk, PolandTaking people
- Uniwersyteckie Centrum Kliniczne w GdańskuGdansk, PolandTaking people
- Górnośląskie Centrum Zdrowia DzieckaKatowice, PolandTaking people
- Uniwersytecki Szpital Dzieciecy w KrakowieKrakow, PolandTaking people
- Centralny Szpital Kliniczny Uniwersytetu Medycznego w ŁodziŁódź, PolandTaking people
- Uniwersytecki Szpital Dziecięcy w LublinieLublin, PolandTaking people
- Szpital Kliniczny Uniwersytetu Medycznego im. Karola Marcinkowskiego w PoznaniuPoznań, PolandTaking people
- Kliniczny Szpital Wojewódzki nr 2 im. Św. Jadwigi Królowej w RzeszowieRzeszów, PolandTaking people
- Uniwersytecki Szpital Klinicznym Nr 1 Pomorskiego Uniwersytetu MedycznegoSzczecin, PolandTaking people
- Instytut Pomnik Centrum Zdrowia DzieckaWarsaw, PolandTaking people
- Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we WrocławiuWrocław, PolandTaking people
- Samodzielny Publiczny Szpital Kliniczny Nr 1 Im.Prof.Stanislawa Szyszko Slaskiego Uniwersytetu Medycznego W KatowicachZabrze, PolandTaking people
About the trial
What the trial wants to find out
1. The possibility of individualizing the treatment of malignant liver tumors in children by classifying them into different groups according to the stage of the disease; 2. The possibility of reducing the occurrence of treatment side effects without significantly affecting the cure rate; 3. Improvement of curability, where current therapy is still not effective enough; 4. Selection of the most effective methods of surgical treatment
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Official title
- A clinical trial in children and adolescents with primary malignant liver cancer - Hepatoblastoma and Hepatocarcinoma
- Plain-language title
- Tests treatment plans for liver cancer in children and teensGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 5 June 2025